Pharmacological evaluation of sedative–hypnotic activity and gastro-intestinal toxicity of Rhizoma Paridis saponins

Ethnopharmacological relevanceRhizoma Paridis saponins (RPS) have been well studied for antimicrobial, anti-hemorrhagic, and anticancer effects. However, scientific information on RPS regarding the toxic and neuropharmacological effects is limited. In this study, the acute oral toxicity, sedative–hypnotic activity and gastro-intestinal toxicity of RPS were investigated.Materials and methodsThe acute toxicity was carried out by administering single doses (800–5000 mg/kg) of RPS to adult mice. Rotarod test and sodium pentobarbital-induced hypnosis activity were used to evaluate the neuropharmacological effects on mice. Gastric emptying and intestinal transit were used to investigate the gastric–intestinal system effects.ResultsA single oral administration of RPS dose-dependently caused adverse effects on the general behavior and mortality rate of mice. LD50 value of oral acute toxicity was 2182.4 mg/kg, with 95% confidence limit of 1718.4–2807.8 mg/kg. In the test of sleeping mice, RPS acted in synergy with sodium pentobarbital at doses 250 and 500 mg/kg while motor coordination was not influenced within 120 min after treatment with RPS. Regarding the gastric–intestinal toxicity, RPS (100, 250, and 500 mg/kg) significantly inhibited gastric emptying but did not affect the intestinal transit.ConclusionsRPS, which is a hypotoxic anticancer drug, possesses the sedative–hypnotic activity and gastric stimulus side effect.

Graphical AbstractFigure optionsDownload high-quality image (473 K)Download as PowerPoint slide